Clinical Trial Update: Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

This document provides an EARLY Phase 1 clinical trial update regarding the use of autologous antigen-activated dendritic cells to treat breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Autologous Antigen-activated Dendritic Cells

Snippet

Sponsor: Research Institute of Fundamental and Clinical Immunology | Conditions: Breast Cancer | EARLY_Phase 1 | Status: UNKNOWN